Clinical Trials Sponsored by Gynea Laboratorios SA

Total 14 results

Instituto Palacios
Gynea Laboratorios SA

Completed

Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis

Candidiasis, Vulvovaginal

Spain
Dr. Reddys Laboratories, SA

Completed

Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts

Common Warts

United States
Hospital Universitari Son Dureta
Laboratorios BIOMED SA

Unknown

Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications (CALCIFICA)

Aortic Stenosis | Heart Valve Disease

Spain
Laboratorios Manuell SA
Universidad Nacional Autonoma de Mexico

Unknown

Co-administration of Thiamine Pyrophosphate and Metformin in Type 2 Diabetes

Diabetes Mellitus, Type 2

Mexico
Haider Mahdi
Dr. Reddys Laboratories, SA

Recruiting

T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors

Epithelial Ovarian Cancer

United States
Coordinación de Investigación en Salud, Mexico
Ultra Laboratorios SA. de CV.

Recruiting

Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 (Omehecatl)

Covid19

Mexico
Centre Hospitalier Intercommunal Creteil
IBSA Institut Biochimique SA; Laboratoires Genévrier

Completed

Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders

Fertility Disorders

France
Laboratório Catarinense SA
Financiadora de Estudos e Projetos; Universidade Federal do Ceará

Terminated

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode (LABCATTCJUSS)

Depression

Brazil
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Terminated

Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis (ANGEL-MS)

Multiple Sclerosis, Relapsing-Remitting

Estonia, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Poland, Russian Federation, Serbia, Spain, Ukraine
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Completed

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS (CHANGE-MS)

Multiple Sclerosis, Relapsing-Remitting

Poland, Ukraine, Germany, Spain, Bulgaria, Serbia, Russian Federation, Hungary, Italy, Croatia, Czechia, Estonia
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Germans Trias i Pujol Hospital; Institut Catala de Salut; Department of Health... and other collaborators

Completed

Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention (HCQ4COV19)

COVID-19

Spain
Monte Verde SA
FLENI Instituto de Rehabilitación y Educación Terapéutica, BA, Argentina.; Bioanalytical... and other collaborators

Completed

Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System

Brain Neoplasms, Malignant, Primary

Argentina
Collège National des Généralistes Enseignants
Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de... and other collaborators

Completed

Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice (ESCAPE)

High Risk Hypertensive Patients

France
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; Cardiff University; Karolinska Institutet and other collaborators

Withdrawn

TINN2: Treat Infection in NeoNates 2 (TINN2)

Bronchopulmonary Dysplasia

Belgium, France, Germany, Hungary, Italy, Luxembourg, Netherlands, Sweden, United Kingdom

Clinical Trials Sponsored by Gynea Laboratorios SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations